Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine
Crossref DOI link: https://doi.org/10.1186/s12885-016-2930-9
Published Online: 2016-11-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Orue, Andrea
Chavez, Valery
Strasberg-Rieber, Mary
Rieber, Manuel
Funding for this research was provided by:
Fonacit-Misión Ciencia (subproyecto SPNS 4-Cancer)
License valid from 2016-11-18